These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 12031866)

  • 1. Advances in prostate cancer immunotherapy.
    Havranek EG; Whelan MA; Greenhalgh R; Dalgleish AG; Pandha H
    Surg Oncol; 2002 Jun; 11(1-2):35-45. PubMed ID: 12031866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progress in active specific immunotherapy of prostate cancer.
    Tjoa BA; Murphy GP
    Semin Surg Oncol; 2000; 18(1):80-7. PubMed ID: 10617899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostate cancer: advances in immunotherapy.
    Hurwitz AA; Yanover P; Markowitz M; Allison JP; Kwon ED
    BioDrugs; 2003; 17(2):131-8. PubMed ID: 12641491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in specific immunotherapy for prostate cancer.
    Kiessling A; Füssel S; Wehner R; Bachmann M; Wirth MP; Rieber EP; Schmitz M
    Eur Urol; 2008 Apr; 53(4):694-708. PubMed ID: 18061335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate cancer gene therapy.
    Ferrer FA; Rodriguez R
    Hematol Oncol Clin North Am; 2001 Jun; 15(3):497-508. PubMed ID: 11525293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunotherapy for Prostate Cancer: Where Do We Go From Here?-PART 1: Prostate Cancer Vaccines.
    Patel A; Fong L
    Oncology (Williston Park); 2018 Mar; 32(3):112-20. PubMed ID: 29548065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunotherapy for prostate cancer: what's the future?
    Arlen PM; Dahut WL; Gulley JL
    Hematol Oncol Clin North Am; 2006 Aug; 20(4):965-83, xi. PubMed ID: 16861126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunology and immunotherapy approaches for prostate cancer.
    Elkord E
    Prostate Cancer Prostatic Dis; 2007; 10(3):224-36. PubMed ID: 17420764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Developing dendritic cell polynucleotide vaccination for prostate cancer immunotherapy.
    Berlyn KA; Ponniah S; Stass SA; Malone JG; Hamlin-Green G; Lim JK; Cottler-Fox M; Tricot G; Alexander RB; Mann DL; Malone RW
    J Biotechnol; 1999 Aug; 73(2-3):155-79. PubMed ID: 10486925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The immunotherapy of prostate and bladder cancer.
    Totterman TH; Loskog A; Essand M
    BJU Int; 2005 Oct; 96(5):728-35. PubMed ID: 16144528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual antigen target-based immunotherapy for prostate cancer eliminates the growth of established tumors in mice.
    Karan D; Dubey S; Van Veldhuizen P; Holzbeierlein JM; Tawfik O; Thrasher JB
    Immunotherapy; 2011 Jun; 3(6):735-46. PubMed ID: 21668311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunotherapeutics in development for prostate cancer.
    Harzstark AL; Small EJ
    Oncologist; 2009 Apr; 14(4):391-8. PubMed ID: 19342474
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostate cancer vaccines: current status and future potential.
    Doehn C; Böhmer T; Kausch I; Sommerauer M; Jocham D
    BioDrugs; 2008; 22(2):71-84. PubMed ID: 18345705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunotherapy and prostate cancer.
    Kaminski JM; Summers JB; Ward MB; Huber MR; Minev B
    Cancer Treat Rev; 2003 Jun; 29(3):199-209. PubMed ID: 12787714
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostate cancer vaccines: current status.
    Hwang LC; Fein S; Levitsky H; Nelson WG
    Semin Oncol; 1999 Apr; 26(2):192-201. PubMed ID: 10597730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Society of Urologic Oncology Biotechnology Forum: new approaches and targets for advanced prostate cancer.
    Belldegrun A; Bander NH; Lerner SP; Wood DP; Pantuck AJ
    J Urol; 2001 Oct; 166(4):1316-21. PubMed ID: 11547065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Active specific immune therapy of prostate gland cancer].
    Chakŭrov S; Minchev M
    Khirurgiia (Sofiia); 2002; 58(1):32-8. PubMed ID: 12515033
    [No Abstract]   [Full Text] [Related]  

  • 18. Enhancement of antitumour immunity by a novel chemotactic antigen DNA vaccine encoding chemokines and multiepitopes of prostate-tumour-associated antigens.
    Qin H; Zhou C; Wang D; Ma W; Liang X; Lin C; Zhang Y; Zhang S
    Immunology; 2006 Mar; 117(3):419-30. PubMed ID: 16476062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunotherapy of metastasis.
    Dallal RM; Lotze MT
    Surg Oncol Clin N Am; 2001 Apr; 10(2):433-47, xi. PubMed ID: 11382596
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA vaccine for cancer immunotherapy.
    Yang B; Jeang J; Yang A; Wu TC; Hung CF
    Hum Vaccin Immunother; 2014; 10(11):3153-64. PubMed ID: 25625927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.